期刊文献+

基于单个B淋巴细胞扩增技术筛选马传染性贫血病毒的囊膜蛋白单克隆抗体

Sorting of EIAV envelop protein monoclonal antibodies based on single B cell amplification technology
下载PDF
导出
摘要 马传染性贫血病毒(EIAV)囊膜蛋白(Env)是参与病毒感染过程中的关键蛋白,由表面蛋白(Gp90)及跨膜蛋白(Gp45)组成,Env蛋白在介导病毒粘附、细胞间融合、疾病传播等方面发挥重要作用。为了通过单个B淋巴细胞扩增技术获得Env特异性单克隆抗体(MAb),本研究利用密码子优化后的Gp90基因构建了重组质粒pcDNA3.1-s-gp90-His,按常规方法将该重组质粒免疫小鼠6次后分离脾细胞,利用荧光激活细胞分选(FACS)技术分离免疫小鼠脾细胞中可识别Gp90的单个B淋巴细胞,结果显示,本研究从2×10^(8)个小鼠脾细胞中获得890个识别Gp90的单个B淋巴细胞。通过特异性引物以单个B淋巴细胞的基因组cDNA为模板扩增抗体重链(Ig VH)和轻链(Ig VL)的可变区基因,利用重叠延伸PCR方法分别将重链(Ig VH)和轻链(Ig VL)可变区基因克隆至pcDNA3.1中,测序鉴定结果显示分别正确构建了27对匹配的pcDNA3.1-VH和pcDNA3.1-VL表达质粒,将这27对匹配的表达质粒分别按照pcDNA3.1-VH:pcDNA3.1-VL=1:1的比例共转染至HEK293F细胞,收获细胞上清,经Protein A纯化获得Gp90 MAb。通过ELISA和western blot两种方法对纯化的Gp90 MAb进行鉴定,结果显示获得了27株可匹配的抗体基因对,经表达后有4株MAb可与Gp90蛋白结合,且可以识别Gp90蛋白的天然构象。本研究首次采用单个B淋巴细胞扩增技术对Gp90 MAb进行了筛选,获得的Gp90 MAb为Env蛋白检测方法的研究提供了物质基础,同时为深入研究Env蛋白的功能奠定了基础。 Equine infectious anemia virus(EIAV)envelope protein(Env)is a key protein involved in the infection process which consists of surface protein(Gp90)and transmembrane protein(Gp45).Env plays an important part in virus adhesion,cell fusion,disease transmission and other aspects.In order to obtain Env-specific monoclonal antibody(MAb),we constructed the codon-optimized Gp90 gene on pcDNA3.1,and built the recombinant plasmid pcDNA3.1-s-gp90-His.According to the conventional method,after immunizing mice with the recombinant plasmid pcDNA3.1-s-gp90-His 6 times,spleen cells were isolated.We used fluorescence activated cell sorting(FACS)technology to isolate the single B lymphocyte that can recognize Gp90 in the spleen cells of immunized mice.890 single B lymphocytes that recognize Gp90 were obtained from 2×10^(8)mouse spleen cells.Then,we amplified the variable region genes of the antibody heavy chain(Ig VH)and light chain(Ig VL)through specific primers using the genomic cDNA of single B lymphocyte as a template,and the heavy chain(Ig VH)and the light chain(Ig VL)variable region gene was ligated to pcDNA3.1 by overlapping PCR.The sequencing and identification results showed that 27 pairs of matching pcDNA3.1-VH and pcDNA3.1-VL expression plasmids were successfully constructed.The plasmids were co-transfected into HEK293F cells at the ratio of pcDNA3.1-VH:pcDNA3.1-VL=1:1,and the cell supernatant was harvested and purified by Protein A column to obtain Gp90 monoclonal antibody.The purified Gp90 monoclonal antibodies were identified by ELISA and western blot.Results showed that 4 monoclonal antibodies can bind with Gp90 protein and recognize the natural conformation of Gp90 protein from 27 matched antibody gene pairs were obtained.This study used single B lymphocyte amplification technology to screen Gp90 monoclonal antibodies for the first time.At the same time,the acquisition of Gp90 monoclonal antibodies provided a basis for the development of Env protein detection methods and laid a foundation for in-depth study of the function of Env protein.
作者 张佳琦 王亚玉 郭兴 林跃智 廖化新 王晓钧 ZHANG Jia-qi;WANG Ya-yu;GUO Xing;LIN Yue-zhi;LIAO Hua-xin;WANG Xiao-jun(State Key Laboratory of Veterinary Biotechnology,Harbin Veterinary Research Institute,Chinese Academy of Agricultural Sciences,Harbin 150069,China;College of Life Science and Technology,Jinan University,Guangzhou 510632,China)
出处 《中国预防兽医学报》 CAS CSCD 北大核心 2022年第3期307-313,共7页 Chinese Journal of Preventive Veterinary Medicine
基金 国家自然科学基金面上项目(31672533) 黑龙江省自然科学基金面上项目(C2016064、C2017077、C2017076) 兽医生物技术国家重点实验室开放课题基金(SKLVBF2017)。
关键词 马传染性贫血病毒 囊膜蛋白 单个B淋巴细胞扩增 单克隆抗体 EIAV Env single B lymphocyte PCR MAb
  • 相关文献

参考文献2

二级参考文献41

  • 1Bogers W M, Cheng-Mayer C, Montelaro R C. 2000. Developments in preclinical aids vaccine efficacy models. AIDS, 14 Suppl 3: S141-s151.
  • 2Burton D R, Desrosiers R C, Doms R W, et al. 2004. Hiv vaccine design and the neutralizing antibody problem. Nat Immunol, 5(3): 233-236.
  • 3Cavarelli M, Karlsson I, Zanchetta M, et al. 2008. Hiv-1 with multiple ccr5/cxcr4 chimeric receptor use is predictive of immunological failure in infected children. PLoS One, 3(9): e3292.
  • 4Clements J E, Zink M C. 1996. Molecular biology and pathogenesis of animal lentivirus infections. Clin Microbial Rev,9(1): 100-117.
  • 5Craigo J K, Zhang B, Barnes S, et al. 2007. Envelope variation as a primary determinant of lentiviral vaccine efficacy. Proe Natl Aead Sei U S A, 104(38): 15105-15110.
  • 6Desrosiers R C. 2004. Prospects for an aids vaccine. Nat Meal, 10(3): 221-223.
  • 7Felsensteln J. 1996. Inferring phylogenies from protein sequences by parsimony, distance, and likelihood methods. Methods Enzymol, 266:418-427.
  • 8Johnson W E, Sanford H, Schwall L, et al. 2003. Assorted mutations in the envelope gene of simian immunodeficiency virus lead to loss of neutralization resistance against antibodies representing a broad spectrum of specificities. J Virol, 77(18): 9993-10003.
  • 9Kuiken C, Korber B, Sharer R W. 2003. Hiv sequence databases. AIDS Rev, 5(1): 52-61.
  • 10Leroux C, Cadore J L, Montelaro R C. 2004. Equine infectious anemia virus (eiav): What has hiv's country cousin got to tell us? Vet Res, 35(4): 485-512.

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部